vesnarinone

vesnarinone

Cardiology A quinolinone with a narrow therapeutic range; withdrawn from the market. See Flosequinan.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).
Mann, "Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone Trial (VEST)," Circulation, vol.
The chemical synthesis and the pharmacologica [studies of tetrahydroquinoline derivatives such as Sumanirole maleate (an anti-depressant for Parkinson's disease) (Hulin and Lopaze 2004) and Vesnarinone (a positive inotropic agent) (Santangelo et al.
In VEST (Vesnarinone Heart Failure Trial) study, the effects of cytokines explain the anemia in 2% of all anemic patients (18).
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure.